Suchergebnisse - "Davies, Jane C"

PubPharm (275)

21

A systematic review to identify and collate factors influencing patient journeys through clinical trials

enthalten in: JRSM open | 2023

von Dobra, R. | Wilson, G. | Matthews, J. | +5

22

Antimicrobial peptide glatiramer acetate targetsPseudomonas aeruginosalipopolysaccharides to breach membranes without altering lipopolysaccharide modification

enthalten in: bioRxiv.org | 2023

von Murphy, R. | Pizzato, J. | Cuthbertson, L. | +6

23

An invisible threat? Aspergillus positive cultures and co-infecting bacteria in airway samples

enthalten in: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | 2023

von Hughes, D. | Rosenthal, M. | Cuthbertson, L. | +10

24

Lytic Bacteriophage Is a Promising Adjunct to Common Antibiotics across Cystic Fibrosis Clinical Strains and Culture Models of Pseudomonas aeruginosa Infection

enthalten in: Antibiotics (Basel, Switzerland) | 2023

von Martin, I. | Morales, S. | Alton, E. | +1

25

Future therapies for cystic fibrosis

enthalten in: Nature communications | 2023

von Allen, L. | Allen, L. | Carr, S. | +10

26

Migration is not the perfect answer : How the cross-talk error correction for multiple breath nitrogen washout (MBWN2 ) parameters differs on directly collected vs. legacy data

enthalten in: Pediatric pulmonology | 2023

von Short, C. | Abkir, M. | Pinnell, S. | +3

27

Hodson and Geddes' Cystic Fibrosis

Erschienen: Milton, Taylor & Francis Group, 2023

5th ed.

von Bush, A. | Amaral, M. | Davies, J. | +3

28

Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation : A Phase 3b, Randomized, Placebo-controlled Study

enthalten in: American journal of respiratory and critical care medicine | 2022

von Mall, M. | Brugha, R. | Gartner, S. | +21

CommentIn: Am J Respir Crit Care Med. 2022 Dec 1;206(11):1308-1310. - PMID 35947636

29

Update on Clinical Outcomes of Highly Effective Modulator Therapy

enthalten in: Clinics in chest medicine | 2022

von Gifford, A. | Taylor-Cousar, J. | Davies, J. | +1

30

New concepts in antimicrobial resistance in cystic fibrosis respiratory infections

enthalten in: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | 2022

von Drevinek, P. | Canton, R. | Johansen, H. | +4